Advances in the Physicochemical Profiling of Opioid Compounds of Therapeutic Interest
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
Abstract
This review focuses on recent developments in the physicochemical profiling of morphine and other opioids. The acid‐base properties and lipophilicity of these compounds is discussed at the microscopic, species‐specific level. Examples are provided where this type of information can reveal the mechanism of pharmacokinetic processes at the submolecular level. The role of lipophilicity in quantitative structure–activity relationship (QSAR) studies of opioids is reviewed. The physicochemical properties and pharmacology of the main metabolites of morphine are also discussed. Recent studies indicate that the active metabolite morphine‐6‐glucuronide (M6G) can contribute to the analgesic activity of systemically administered morphine. The unexpectedly high lipophilicity of M6G partly accounts for its analgesic activity. When administered parenterally, another suspected minor metabolite, morphine‐6‐sulfate (M6S) has superior antinociceptive effects to those of morphine. However, because sulfate esters of morphine derivatives cannot cross the blood‐brain barrier these esters may be good candidates to develop peripheral analgesic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry
Beale, J. M., & Block, J. H. (2011) · Andalas University Repository (Andalas University) · Cited by 914
Abraham, M. H., Chadha, H. S., Whiting, G. S., & Mitchell, R. C. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830806 · Cited by 766
van de Waterbeemd, H., Camenisch, G., Folkers, G., Chretien, J. R., & Raevsky, O. A. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997889 · Cited by 587
Clinical Pharmacology of Opioids for Pain
Inturrisi, C. E. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200207001-00002 · Cited by 571
CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure
Rankovic, Z. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501535r · Cited by 548
Wager, T. T., Chandrasekaran, R. Y., Hou, X., Troutman, M. D., Verhoest, P. R., Villalobos, A., & Will, Y. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100007x · Cited by 477
Absorption and Drug Development: Solubility, Permeability, and Charge State
Avdeef, A. (2012) · Wiley eBooks · doi:10.1002/9781118286067 · Cited by 446
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.
Paul, D., Standifer, K. M., Inturrisi, C. E., & Pasternak, G. W. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20832-1 · Cited by 393
Lipid solubility and drug penetration of the blood brain barrier
Oldendorf, W. H. (1974) · Experimental Biology and Medicine · doi:10.3181/00379727-147-38444 · Cited by 373
The significance of acid/base properties in drug discovery
Manallack, D. T., Prankerd, R. J., Yuriev, E., Oprea, T. I., & Chalmers, D. K. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35348b · Cited by 329
Waring, M. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.109 · Cited by 326
Milne, R. W., Nation, R. L., & Somogyi, A. A. (1996) · Drug Metabolism Reviews · doi:10.3109/03602539608994011 · Cited by 215
Carrupt, P. A., Testa, B., Bechalany, A., El Tayar, N., Descas, P., & Perrissoud, D. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00108a005 · Cited by 214
Kaufman, J. J., Semo, N. M., & Koski, W. S. (1975) · Journal of Medicinal Chemistry · doi:10.1021/jm00241a001 · Cited by 212
Tzvetkov, M. V., dos Santos Pereira, J. N., Meineke, I., Saadatmand, A. R., Stingl, J. C., & Brockmöller, J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.019 · Cited by 206
Dagenais, C., Rousselle, C., Pollack, G. M., & Scherrmann, J.-M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200002000-00020 · Cited by 202
Liu, X., Smith, B. J., Chen, C., Callegari, E., Becker, S. L., Chen, X., Cianfrogna, J., Doran, A. C., Doran, S. D., Gibbs, J. P., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079319 · Cited by 181
Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
Frances, B., Gout, R., Monsarrat, B., Cros, J., & Zajac, J. M. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10743-x · Cited by 163
Morphine metabolism, transport and brain disposition
De Gregori, S., De Gregori, M., Ranzani, G. N., Allegri, M., Minella, C., & Regazzi, M. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-011-9274-6 · Cited by 160
Intrathecal opioids, potency and lipophilicity
McQuay, H. J., Sullivan, A. F., Smallman, K., & Dickenson, A. H. (1989) · Pain · doi:10.1016/0304-3959(89)90118-8 · Cited by 157
Avdeef, A., & Testa, B. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012496 · Cited by 151
Sverrisdóttir, E., Lund, T. M., Olesen, A. E., Drewes, A. M., Christrup, L. L., & Kreilgaard, M. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.03.020 · Cited by 149
Lipophilicity Profiles of Ampholytes
Pagliara, A., Carrupt, P., Caron, G., Gaillard, P., & Testa, B. (1997) · Chemical Reviews · doi:10.1021/cr9601019 · Cited by 145
Klimas, R., & Mikus, G. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu186 · Cited by 143
On the Partition of Ampholytes: Application to Blood–Brain Distribution
Abraham, M. H., Takács‐Novák, K., & Mitchell, R. C. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960328j · Cited by 141
Biochemical basis for analgesic activity of morphine-6-glucuronide—I
Yoshimura, H., Îda, S., Oguri, K., & Tsukamoto, H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90320-1 · Cited by 140
L??tsch, J., & Geißlinger, G. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00001 · Cited by 134
Bickel, U., Schumacher, O. P., Kang, Y. S., & Voigt, K. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20113-6 · Cited by 128
Bourasset, F., Cisternino, S., Temsamani, J., & Scherrmann, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01990.x · Cited by 122
Wu, D., Kang, Y., Bickel, U., & Pardridge, W. M. (1997) · PubMed · Cited by 119
Avdeef, A., Barrett, D. A., Shaw, P. N., Knaggs, R., & Davis, S. S. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960073m · Cited by 99
Aasmundstad, T. A., Mørland, J., & Paulsen, R. E. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12068-5 · Cited by 93
DARK Classics in Chemical Neuroscience: Morphine
Devereaux, A. L., Mercer, S. L., & Cunningham, C. W. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00150 · Cited by 85
Kutter, E., Herz, A., Teschemacher, H. J., & Hess, R. (1970) · Journal of Medicinal Chemistry · doi:10.1021/jm00299a003 · Cited by 84
Morphine-6-Glucuronide: Morphine??s Successor for Postoperative Pain Relief?
van Dorp, E. L. A., Romberg, R. R., Sarton, E. Y., Bovill, J. G., & Dahan, A. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000217197.96784.c3 · Cited by 81
Gulaboski, R., Cordeiro, M. N. D. S., Milhazes, N., Garrido, J. M. P. J., Borges, F., Jorge, M., Pereira, C. M. D. M., Bogeski, I., Helguera, A. M., Naumoski, B., et al. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.11.006 · Cited by 69
Gaillard, P., Carrupt, P., & Testa, B. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80191-8 · Cited by 60
Influence of polarity on dose-response relationships of intrathecal opioids in rats
Plummer, J. L., Cmielewski, P., Reynolds, G. D., Gourlay, G. K., & Cherry, D. A. (1990) · Pain · doi:10.1016/0304-3959(90)91131-2 · Cited by 58
Morphine‐6‐glucuronide (M6G) for postoperative pain relief
Dahan, A., van Dorp, E., Smith, T., & Yassen, A. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2007.07.009 · Cited by 50
Drug delivery: A process governed by species-specific lipophilicities
Mazák, K., & Noszál, B. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.05.017 · Cited by 44
Self-citationNoszál, B., & Rabenstein, D. L. (1991) · The Journal of Physical Chemistry · doi:10.1021/j100165a031 · Cited by 44
Self-citationMazák, K., & Noszál, B. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.03.053 · Cited by 37
Self-citationThe chemical and pharmacological importance of morphine analogues
Fürst, S., & Hosztafi, S. (2008) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.95.2008.1.1 · Cited by 36
Self-citationOsborne, P. B., Chieng, B. C. H., & Christie, M. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703697 · Cited by 35
Murphey, L. J., & Olsen, G. D. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22725-2 · Cited by 33
Port, A., Bordas, M., Enrech, R., Pascual, R., Rosés, M., Ràfols, C., Subirats, X., & Bosch, E. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.07.010 · Cited by 33
Shim, J., Coop, A., & MacKerell, A. D. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp202542g · Cited by 26
Lipophilicity of morphine microspecies and their contribution to the lipophilicity profile
Mazák, K., & Noszál, B. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.11.007 · Cited by 22
Self-citationLackó, E., Riba, P., Giricz, Z., Váradi, A., Cornic, L., Balogh, M., Király, K. P., Csekő, K., Mousa, S. A., Hosztafi, S., et al. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.233551 · Cited by 22
Self-citationYadlapalli, J. S. K., Ford, B. M., Ketkar, A. D., Wan, A., Penthala, N. R., Eoff, R. L., Prather, P. L., Dobretsov, M. G., & Crooks, P. A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.012 · Cited by 22
Advances in Drug Research, vol. 5
(1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600643 · Cited by 20
Species-specific lipophilicity of morphine antagonists
Mazák, K., Hosztafi, S., & Noszál, B. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.06.026 · Cited by 19
Self-citationPallicer, J. M., Pascual, R., Port, A., Rosés, M., Ràfols, C., & Bosch, E. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.008 · Cited by 19
Structural and Physicochemical Profiling of Morphine and Related Compounds of Therapeutic Interest
Mazák, K., Hosztafi, S., Rácz, Á., & Noszál, B. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788681555 · Cited by 17
Self-citationComparative distribution of opiate agonists and antagonists by means of double isotope techniques
Fishman, J., Hahn, E. F., & Norton, B. I. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90333-1 · Cited by 16
Andersson, M., Björkhem‐Bergman, L., Ekström, L., Bergqvist, L. L., Lagercrantz, H., Rane, A., & Beck, O. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.71 · Cited by 14
Lipophilicity of opioids determined by a novel micromethod
Medzihradsky, F., Emmerson, P. J., & Mousigian, C. A. (1992) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/1056-8719(92)90023-t · Cited by 13
Morphine metabolites as novel analgesic drugs?
Lötsch, J. (2004) · Current Opinion in Anaesthesiology · doi:10.1097/00001503-200410000-00016 · Cited by 12
Physico-chemical profiling of semisynthetic opioids
Mazák, K., Hosztafi, S., Kraszni, M., & Noszál, B. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.12.014 · Cited by 12
Self-citationPhysicochemical and Pharmacological Characterization of Permanently Charged Opioids
Mazák, K., Noszál, B., & Hosztafi, S. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170705112239 · Cited by 11
Self-citationPreechagoon, D., Smith, M. T., & Prankerd, R. J. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00380-3 · Cited by 7
Hydrophobic forms of morphine-6-glucosides
Schwarzinger, S., Hartmann, M., Kremminger, P., & Müller, N. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00255-4 · Cited by 5
Ae, J. (1978) · PubMed · Cited by 1
Research works printed but not linked: 5
- 14. T. L. Yaksh, M. S. Wallace, Goodman & Gilman's The Pharmaceutical Basis of Therapeutics (Eds.: L. L. Brunton, B. A. Chabner, B. C. Knollmann), McGraw-Hill Medical 2010, pp. 481-527.
- 23. A. E. Jacobson, W. A. Klee, W. J. Dunn, Eur. J. Med. Chem. 1977, 12, 49- 52.
- 24. A. E. Jacobson, NIDA Res. Monogr. 1978, 22, 129-45.
- 48. D. Wu, Y. S. Kang, U. Bickel, W. M. Pardridge, Drug Metab. Dispos. 1997, 25, 768-771.
- 60. J. Lötsch, G. Geisslinger, Clin. Pharmacokinet. 2001, 40, 485-499.
Cited by
Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic
Balyan, R., Hahn, D., Huang, H. D., & Chidambaran, V. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1721458 · Cited by 31
“[30] and will not be presented further here).”
BackgroundOpioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
Shaabani, N., Chan, N. W. C., Lee, W. E., & Jemere, A. B. (2020) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/abbb0d · Cited by 27
Physicochemical Properties of Zwitterionic Drugs in Therapy
Mazák, K., & Noszál, B. (2020) · ChemMedChem · doi:10.1002/cmdc.202000164 · Cited by 23
Self-citationA Molecularly Imprinted Sol-Gel Electrochemical Sensor for Naloxone Determination
Shaabani, N., Chan, N. W. C., & Jemere, A. B. (2021) · Nanomaterials · doi:10.3390/nano11030631 · Cited by 23
“55 and it exists in four tautomeric forms in solution [51].”
Background
Metadata
- Authors
- Mazák, K., Noszál, B., & Hosztafi, S.
- Affiliations
- Semmelweis University (HU)
- Corresponding author
- Mazák, Károly
- Venue
- ChemistryOpen
- Publisher
- Wiley
- Published
- 2019-07
- Volume
- 8
- Issue
- 7
- Pages
- 879-887
- ISSN
- 2191-1363 (ISSN-L)
- PMC
- PMC6610444
- OpenAlex
- W2955693718
- Semantic Scholar
- 922c3a0bc3e9d60e0d7c75fff264b3098df2f0dd
- Cited by
- 27
- References
- 65
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 1
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- ChemistryOpen (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fonds National de la Recherche Luxembourg
- Hungarian Scientific Research Fund (T 73804)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Keywords
- morphine, opioids, physicochemical profiling, lipophilicity, acid-base properties, pharmacokinetics, QSAR, morphine metabolites, morphine-6-glucuronide, analgesic activity, blood-brain barrier, peripheral analgesics, antinociception
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.